findmyKOL
Clinical trialNCT02460432CompletedInterventional

Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)

SponsorTaewoong Medical Co., Ltd.Enrollment106Biliary NeoplasmsBiliary ObstructionPancreatic Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Inje University Busan Paik Hospital

    Busan, Bokji-ro Busanjin-gu, South Korea

  • Seoul National University Hospital

    Seoul, Haehak-ro Jongno-gu, South Korea

  • in Ha University Hospital

    Incheon, Inhang-ro Jung-gu, South Korea

  • Samsung Medical Center

    Seoul, Irwon-Dong, Gangnam-Gu, South Korea

  • Gangnam Severance Hospital

    Seoul, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2015
Primary completion
26 Dec 2016
Completion
26 Dec 2016
Last update posted
11 Apr 2017
Registered enrollment
106
Registry id
NCT02460432

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.